Monday, October 16, 2017 1:48:21 PM
Sen. Manchin calls on Trump to withdraw Marino’s nomination as drug czar in wake of Post/‘60 Minutes’ probe
By Ed O'Keefe, Scott Higham and Lenny Bernstein October 16 at 1:14 PM
Rep. Tom Marino (R-Pa.), left, talks to Rep. Trey Gowdy (R-S.C.) in November 2015. (Andrew Harrer/Bloomberg News)
Congressional Democrats reacted sharply Monday to reports that President Trump’s nominee to serve as the nation’s drug czar helped steer legislation that made it harder for the government to take some enforcement actions against giant drug companies.
One Democratic senator called on Trump to withdraw the nomination of Rep. Tom Marino (R-Pa.) [ https://www.washingtonpost.com/investigations/rep-tom-marino-drug-czar-nominee-and-the-opioid-industrys-advocate-in-congress/2017/10/15/555211a0-b03a-11e7-9e58-e6288544af98_story.html?utm_term=.4bbf9a6c879b ] to lead the Office of National Drug Control Policy, a position requiring Senate confirmation. Another quickly introduced legislation to undo the law that Marino championed and that passed Congress with little opposition.
In a statement, Sen. Joe Manchin III (D-W.Va.) said he was “horrified” to read details of an investigation by The Washington Post and “60 Minutes” that detailed how a targeted lobbying effort helped weaken the Drug Enforcement Administration’s ability to go after drug distributors, even as opioid-related deaths continue to rise. He called on Trump to withdraw Marino’s nomination
[...]
https://www.washingtonpost.com/powerpost/manchin-calls-on-trump-to-withdraw-marinos-nomination-as-drug-czar-in-wake-of-post60-minutes-probe/2017/10/16/b73ee1be-b287-11e7-be94-fabb0f1e9ffb_story.html?utm_term=.403a19950d4c
By Ed O'Keefe, Scott Higham and Lenny Bernstein October 16 at 1:14 PM
Rep. Tom Marino (R-Pa.), left, talks to Rep. Trey Gowdy (R-S.C.) in November 2015. (Andrew Harrer/Bloomberg News)
Congressional Democrats reacted sharply Monday to reports that President Trump’s nominee to serve as the nation’s drug czar helped steer legislation that made it harder for the government to take some enforcement actions against giant drug companies.
One Democratic senator called on Trump to withdraw the nomination of Rep. Tom Marino (R-Pa.) [ https://www.washingtonpost.com/investigations/rep-tom-marino-drug-czar-nominee-and-the-opioid-industrys-advocate-in-congress/2017/10/15/555211a0-b03a-11e7-9e58-e6288544af98_story.html?utm_term=.4bbf9a6c879b ] to lead the Office of National Drug Control Policy, a position requiring Senate confirmation. Another quickly introduced legislation to undo the law that Marino championed and that passed Congress with little opposition.
In a statement, Sen. Joe Manchin III (D-W.Va.) said he was “horrified” to read details of an investigation by The Washington Post and “60 Minutes” that detailed how a targeted lobbying effort helped weaken the Drug Enforcement Administration’s ability to go after drug distributors, even as opioid-related deaths continue to rise. He called on Trump to withdraw Marino’s nomination
[...]
https://www.washingtonpost.com/powerpost/manchin-calls-on-trump-to-withdraw-marinos-nomination-as-drug-czar-in-wake-of-post60-minutes-probe/2017/10/16/b73ee1be-b287-11e7-be94-fabb0f1e9ffb_story.html?utm_term=.403a19950d4c
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
